| PTO Form 1478 (Rev 9/2006) |
| OMB No. 0651-0009 (Exp 02/28/2018) |
Trademark/Service Mark Application, Principal Register
TEAS Plus Application
| Serial Number: 86790349 |
| Filing Date: 10/16/2015 |
NOTE: Data fields with the * are mandatory under TEAS Plus. The wording "(if applicable)" appears where the field is only mandatory under the facts of the particular
application.
The table below presents the data as entered.
Input Field
|
Entered
|
| TEAS Plus |
YES |
| MARK INFORMATION |
| *MARK |
ABREVA |
| *STANDARD CHARACTERS |
YES |
| USPTO-GENERATED IMAGE |
YES |
| LITERAL ELEMENT |
ABREVA |
| *MARK STATEMENT |
The mark consists of standard characters, without claim to any particular font, style, size, or color. |
| REGISTER |
Principal |
| APPLICANT INFORMATION |
| *OWNER OF MARK |
GlaxoSmithKline Consumer Healthcare (UK) IP Limited |
| *STREET |
980 Great West Road |
| *CITY |
Brentford, Middlesex |
| *COUNTRY |
England |
*ZIP/POSTAL CODE
(Required for U.S. applicants) |
TW89GS |
| EMAIL ADDRESS |
XXXX |
| LEGAL ENTITY INFORMATION |
| *TYPE |
LIMITED LIABILITY COMPANY |
| * STATE/COUNTRY WHERE LEGALLY ORGANIZED |
England |
| GOODS AND/OR SERVICES AND BASIS INFORMATION |
| *INTERNATIONAL CLASS |
003 |
| *IDENTIFICATION |
Lip balm |
| *FILING BASIS |
SECTION 1(b) |
| ADDITIONAL STATEMENTS INFORMATION |
*TRANSLATION
(if applicable) |
|
*TRANSLITERATION
(if applicable) |
|
*CLAIMED PRIOR REGISTRATION
(if applicable) |
|
*CONSENT (NAME/LIKENESS)
(if applicable) |
|
*CONCURRENT USE CLAIM
(if applicable) |
|
| ATTORNEY INFORMATION |
| NAME |
Terence A. Dixon |
| ATTORNEY DOCKET NUMBER |
TMID5121041 |
| FIRM NAME |
GSK |
| INTERNAL ADDRESS |
NY0300 |
| STREET |
5 Crescent Drive |
| CITY |
Philadelphia |
| STATE |
Pennsylvania |
| COUNTRY |
United States |
| ZIP/POSTAL CODE |
19112 |
| EMAIL ADDRESS |
trademarks@gsk.com |
| AUTHORIZED TO COMMUNICATE VIA EMAIL |
Yes |
| OTHER APPOINTED ATTORNEY |
Charles M. Aktinson, Christopher M. Hanes, Diane Fry Maginnis, Angela L. Wilson |
| CORRESPONDENCE INFORMATION |
| *NAME |
Terence A. Dixon |
| FIRM NAME |
GSK |
| INTERNAL ADDRESS |
NY0300 |
| *STREET |
5 Crescent Drive |
| *CITY |
Philadelphia |
*STATE
(Required for U.S. applicants) |
Pennsylvania |
| *COUNTRY |
United States |
| *ZIP/POSTAL CODE |
19112 |
| *EMAIL ADDRESS |
trademarks@gsk.com |
| *AUTHORIZED TO COMMUNICATE VIA EMAIL |
Yes |
| FEE INFORMATION |
| APPLICATION FILING OPTION |
TEAS Plus |
| NUMBER OF CLASSES |
1 |
| FEE PER CLASS |
225 |
| *TOTAL FEE PAID |
225 |
| SIGNATURE INFORMATION |
| * SIGNATURE |
/tad/ |
| * SIGNATORY'S NAME |
Terence A. Dixon |
| * SIGNATORY'S POSITION |
Attorney for Applicant, PA bar member |
| SIGNATORY'S PHONE NUMBER |
215-751-7653 |
| * DATE SIGNED |
10/16/2015 |
| PTO Form 1478 (Rev 9/2006) |
| OMB No. 0651-0009 (Exp 02/28/2018) |
Trademark/Service Mark Application, Principal Register
TEAS Plus Application
| Serial Number: 86790349 |
| Filing Date: 10/16/2015 |
To the Commissioner for Trademarks:
MARK: ABREVA (Standard Characters, see
mark)
The literal element of the mark consists of ABREVA.
The mark consists of standard characters, without claim to any particular font, style, size, or color.
The applicant, GlaxoSmithKline Consumer Healthcare (UK) IP Limited, a limited liability company legally organized under the laws of England, having an address of
980 Great West Road
Brentford, Middlesex TW89GS
England
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
For specific filing basis information for each item, you must view the display within the Input Table.
International Class 003: Lip balm
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services. (15 U.S.C. Section 1051(b)).
The applicant's current Attorney Information:
Terence A. Dixon and Charles M. Aktinson, Christopher M. Hanes, Diane Fry Maginnis, Angela L. Wilson of GSK
NY0300
5 Crescent Drive
Philadelphia, Pennsylvania 19112
United States
The attorney docket/reference number is TMID5121041.
| The applicant's current Correspondence Information: |
| Terence A. Dixon |
| GSK |
NY0300
5 Crescent Drive |
| Philadelphia, Pennsylvania 19112 |
trademarks@gsk.com (authorized)
E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant or applicant's attorney at the e-mail address provided above. I understand
that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic
Application System (TEAS). Failure to do so will result in an additional processing fee of $50 per international class of goods/services. |
A fee payment in the amount of $225 has been submitted with the application, representing payment for 1 class(es).
Declaration
The signatory believes that: if the applicant is filing the application under 15 U.S.C. § 1051(a), the applicant is the owner of the trademark/service mark sought to be registered; the applicant is
using the mark in commerce on or in connection with the goods/services in the application; the specimen(s) shows the mark as used on or in connection with the goods/services in the application;
and/or if the applicant filed an application under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e), the applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in
connection with the goods/services in the application. The signatory believes that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have
the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause
confusion or mistake, or to deceive. The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such
willful false statements and the like may jeopardize the validity of the application or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and
all statements made on information and belief are believed to be true.
Signature: /tad/ Date Signed: 10/16/2015
Signatory's Name: Terence A. Dixon
Signatory's Position: Attorney for Applicant, PA bar member
RAM Sale Number: 86790349
RAM Accounting Date: 10/16/2015
Serial Number: 86790349
Internet Transmission Date: Fri Oct 16 13:33:04 EDT 2015
TEAS Stamp: USPTO/FTK-XXX.XX.XX.X-201510161333049375
23-86790349-540ac5ef41e748e25669e39deb0e
af8bbc38b16127a77aad4a944abafac8eb3b3-DA
-10342-20151015142801308723
